Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/2010
08/05/2010US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197664 Novel b1-antagonists
08/05/2010US20100197663 Method and compositions for treatment of painful disorders
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010US20100197641 Formulation for lipophilic agents
08/05/2010US20100197623 Anti-Infammatory Macrolide
08/05/2010US20100197622 Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof
08/05/2010US20100197605 Therapeutic use of peptide yglf and combination with kvlpvpq
08/05/2010US20100197603 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
08/05/2010US20100197602 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection
08/05/2010US20100197586 Use of secretin and optionally urodilatin as therapeutic agents
08/05/2010US20100197583 Glycosaminoglycan-antagonising MCP-1 Mutants and Methods of Using Same
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100197564 Diaryl morpholines as cb1 modulators
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196522 Compositions containing amines and use thereof
08/05/2010US20100196496 Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
08/05/2010US20100196492 Electrostatic coating of particles for drug delivery
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196481 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
08/05/2010US20100196475 Controlled release tablet formulation containing magnesium aluminometasilicate
08/05/2010US20100196474 Gastric Retentive Extended-Release Dosage Forms Comprising Combinations of a Non-Opioid Analgesic and an Opioid Analgesic
08/05/2010US20100196473 Pharmaceutical Composition Containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with Delayed Active Ingredient Release
08/05/2010US20100196472 Modified release compositions of milnacipran
08/05/2010US20100196471 Novel tablet dosage form
08/05/2010US20100196466 Drug delivery system
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196442 Methods for treating open wounds
08/05/2010US20100196429 Oil-In-Water Emulsion Composition And Method For Producing The Same
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196404 Methods of use of the taci/taci-l interaction
08/05/2010US20100196402 Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196374 Methods and compositions for treating autoimmune disease
08/05/2010US20100196340 Lactid acid bacteria as priobiotic strains and compositions containing same
08/05/2010US20100196318 Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196281 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196269 Spirocyclic heterocyclic derivatives and methods of their use
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010CA2751239A1 Azetidines as histamine h3 receptor antagonists
08/05/2010CA2751041A1 Prophylactic agent or therapeutic agent for disease resulting from abnormal bone metabolism
08/05/2010CA2751033A1 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/05/2010CA2749884A1 Bicyclic pyrazolo-heterocycles
08/05/2010CA2748847A1 Anti-inflammatory macrolide
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/04/2010EP2211865A2 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases
08/04/2010EP1901759B1 Immunostimulatory method
08/04/2010EP1438015B1 Cosmetic and dermopharmaceutical compositions for skin prone to acne
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN101796073A Humanized antibodies against CXCR3
08/04/2010CN101796036A 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators
08/04/2010CN101795699A wolfberries and inflammation
08/04/2010CN101792765A Small RNA of human-mouse homologous Caspase-3 and application thereof
08/04/2010CN101792694A Candle serving as massage oil
08/04/2010CN101792493A Method for preparing spreading hedyotis herb polysaccharide
08/04/2010CN101792436A Benzimidazole derivatives used in the treatment of diseases associated with vanilloid receptor 1
08/04/2010CN101791367A Traditional Chinese medicine plaster for activating blood circulation and relieving pain
08/04/2010CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera
08/04/2010CN101791361A Vacuum freeze-drying process for retaining medicative active components of traditional Chinese medicine of radix tetrastigme
08/04/2010CN101791344A Traditional Chinese medicine and preparation method thereof
08/04/2010CN101791335A Total alkaloid mixture sourcing from Chinese medicina plant lotus plumule and extraction and preparation method thereof
08/04/2010CN101791312A Use of tetrahydroisoquinoline derivatives
08/04/2010CN101791150A Production method of silica gel sheet containing traditional Chinese medicines and being used for the health underpants
08/04/2010CN101791034A Production method of Rabdosia rubescens gum
08/04/2010CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof
08/04/2010CN101053408B Preparation method for pepper food additive containing purging fire factor
08/04/2010CN101044141B Purine derivatives for use as adenosin A-2A receptor agonists
08/04/2010CN101006860B Smoke-roasting bamboo salt and its making method
08/03/2010US7767850 S-[2-[(1-iminoethy)amino]ethyl]-2-methyl-L-cysteine maleate hydrochloride crystalline salt
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
08/03/2010CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
07/2010
07/29/2010WO2010085724A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
07/29/2010WO2010085582A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
07/29/2010WO2010085581A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
07/29/2010WO2010085570A1 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
07/29/2010WO2010085246A1 2,4-diamino-1,3,5-triazine and 4, 6-diamino-pyrimidine derivatives and their use as aggrecanase inhibitors
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084851A1 Peptide capable of binding to immunoglobulin
07/29/2010WO2010084798A1 Tricyclic compound
07/29/2010WO2010084797A1 Hetero atom-containing compound
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084637A1 Tablet for oral administration having excellent disintegrability and dissolvability
1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 1272